Creekmur Asset Management LLC Raises Holdings in Intuitive Surgical, Inc. $ISRG

Creekmur Asset Management LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 172.1% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 2,416 shares of the medical equipment provider’s stock after acquiring an additional 1,528 shares during the period. Creekmur Asset Management LLC’s holdings in Intuitive Surgical were worth $1,313,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Norway Savings Bank boosted its position in shares of Intuitive Surgical by 53.4% during the second quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock worth $1,420,000 after buying an additional 910 shares during the period. IronOak Wealth LLC. purchased a new position in Intuitive Surgical in the second quarter valued at $1,099,000. Trust Co. of Oklahoma purchased a new position in Intuitive Surgical in the second quarter valued at $363,000. Neville Rodie & Shaw Inc. boosted its holdings in Intuitive Surgical by 11.9% in the second quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock valued at $5,666,000 after purchasing an additional 1,110 shares during the period. Finally, Bessemer Group Inc. boosted its holdings in Intuitive Surgical by 89.3% in the second quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock valued at $428,386,000 after purchasing an additional 371,806 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $530.02 on Friday. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The stock has a market cap of $190.00 billion, a PE ratio of 70.11, a P/E/G ratio of 4.94 and a beta of 1.61. The stock’s fifty day moving average is $463.16 and its two-hundred day moving average is $498.23.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same period last year, the firm earned $1.84 earnings per share. Intuitive Surgical’s quarterly revenue was up 22.9% on a year-over-year basis. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, insider Gary S. Guthart sold 2,800 shares of Intuitive Surgical stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $546.27, for a total transaction of $1,529,556.00. Following the sale, the insider owned 17,120 shares in the company, valued at approximately $9,352,142.40. The trade was a 14.06% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Craig H. Barratt sold 2,193 shares of Intuitive Surgical stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $548.01, for a total value of $1,201,785.93. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 96,011 shares of company stock valued at $50,309,042. 0.70% of the stock is owned by insiders.

Analyst Ratings Changes

ISRG has been the subject of a number of recent research reports. Leerink Partners lifted their target price on Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Mizuho set a $575.00 target price on Intuitive Surgical in a report on Wednesday, October 22nd. Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Sunday, October 26th. HSBC lifted their target price on Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Finally, Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Friday, October 24th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $608.92.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.